Effectiveness of antitussives, anticholinergics, and honey versus usual care in adults with uncomplicated acute bronchitis: a multiarm randomized clinical trial

Carl Llor, Ana Moragas, Dan Ouchi, Ramon Monfà, Ana Garcia-Sangenís, Ainhoa Gómez-Lumbreras, Helena Pera, Jesus Pujol, Rosa Morros, Carl Llor, Ana Moragas, Dan Ouchi, Ramon Monfà, Ana Garcia-Sangenís, Ainhoa Gómez-Lumbreras, Helena Pera, Jesus Pujol, Rosa Morros

Abstract

Background: Despite the frequent use of symptomatic therapies in cough, evidence of their benefits is lacking.

Objective: We compared the effectiveness of 3 symptomatic therapies and usual care in acute bronchitis.

Methods: Multicenter, pragmatic, multiarm parallel group, open randomized trial in primary care (ClinicalTrials.gov, Identifier: NCT03738917) was conducted in Catalonia. Patients ≥18 with uncomplicated acute bronchitis, with cough<3 weeks as the main symptom, scoring ≥4 in either daytime or nocturnal cough (7-point Likert scale), were randomized to usual care, dextromethorphan 15 mg t.i.d., ipratropium bromide inhaler 20 µg 2 puffs t.i.d, or 30 mg of honey t.i.d., all taken for up to 14 days. The main outcome measure was the number of days with moderate-to-severe cough. A symptom diary was given. A second visit was scheduled at days 2-3 for assessing evolution, with 2 more visits at days 15 and 29 for clinical assessment, evaluation of adverse effects, re-attendance, and complications.

Results: We failed to achieve the sample size scheduled due to the COVID-19 pandemic. We finally recruited 194 patients. The median number of days with moderate-to-severe cough (score ≥ 3) in the usual care arm was 5 (interquartile range [IQR], 4, 8.75), 5 in the ipratropium bromide arm (IQR, 3, 8), 5 in the dextromethorphan arm (IQR, 4, 9.75), and 6 in the honey arm (IQR, 3.5, 7). The same results were obtained in the Kaplan-Meier survival analysis for the median survival time of each arm with the usual care as the reference group.

Conclusion: The symptomatic treatment evaluated has shown to be ineffective against cough.

Keywords: antitussive agents; cough; dextromethorphan; honey; ipratropium; randomized controlled trial.

© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Figures

Figure 1.
Figure 1.
Patient randomization flowchart.
Figure 2.
Figure 2.
Kaplan–Meier survival analysis of days with moderate-to-severe cough, that is, time (days) from baseline visit until patient last scored ≥3 in either daytime or nocturnal cough in the symptom diary.

References

    1. Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M, Ortqvist A, Schaberg T, Torres A, van der Heijden G, et al. . Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections—summary. Clin Microbiol Infect. 2011;17(Suppl 6):1–24.
    1. Pouwels KB, Hopkins S, Llewelyn MJ, Walker AS, McNulty C, Robotham JV. Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ. 2019;364:l440.
    1. Smith SM, Fahey T, Smucny J, Becker LA. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017;6(6):CD000245.
    1. Albert RH. Diagnosis and treatment of acute bronchitis. Am Fam Phys. 2010;82(11):1345–1350.
    1. Hamoen M, Broekhuizen BD, Little P, Melbye H, Coenen S, Goossens H, Butler CC, Francis NA, Verheij TJM; GRACE Clinical Study Group. Medication use in European primary care patients with lower respiratory tract infection: an observational study. Br J Gen Pract. 2014;64(619):e81–e91.
    1. Smith SM, Schroeder K, Fahey T. Over-the-counter (OTC) medications for acute cough in children and adults in community settings. Cochrane Database Syst Rev. 2014;(11):CD001831.
    1. Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):95S–103S.
    1. Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J. 1994;7(7):1239–1245.
    1. Becker LA, Hom J, Villasis-Keever M, van der Wouden JC. Beta2-agonists for acute cough or a clinical diagnosis of acute bronchitis. Cochrane Database Syst Rev. 2015;(9):CD001726.
    1. Cayley WE. Beta2 agonists for acute cough or a clinical diagnosis of acute bronchitis. Am Fam Phys. 2017;95(9):551–552.
    1. Oduwole O, Udoh EE, Oyo-Ita A, Meremikwu MM. Honey for acute cough in children. Cochrane Database Syst Rev. 2018;(4):CD007094.
    1. Arentz S, Hunter J, Khamba B, Mravunac M, Lee Z, Alexander K, Lauche R, Goldenberg J, Myers SP. Honeybee products for the treatment and recovery from viral respiratory infections including SARS-COV-2: a rapid systematic review. Integr Med Res. 2021;10(Suppl):100779.
    1. (accessed 17 September 2022).
    1. Cots JM, Moragas A, García-Sangenís A, Morros R, Gomez-Lumbreras A, Ouchi D, Monfà R, Pera H, Pujol J, Bayona C, et al. . Effectiveness of antitussives, anticholinergics or honey versus usual care in adults with uncomplicated acute bronchitis: a study protocol of an open randomised clinical trial in primary care. BMJ Open. 2019;9(5):e028159.
    1. de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, Rotaeche del Campo R, Torán Monserrat P, Negrete Palma A, Muñoz Ortiz L, et al. Delayed Antibiotic Prescription (DAP) Group. Prescription strategies in acute uncomplicated respiratory infections: A randomized clinical trial. JAMA Intern Med. 2016;176(1):21–29.
    1. Morice A, Kardos P. Comprehensive evidence-based review on European antitussives. BMJ Open Respir Res. 2016;3(1):e000137.
    1. Melbye H, Aasebø U, Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebo-controlled double-blind study. Fam Pract. 1991;8(3):216–222.
    1. Higenbottam TW. Anticholinergics and cough. Postgrad Med J. 1987;63(Suppl 1):75–78.
    1. Zanasi A, Lecchi M, del Forno M, Fabbri E, Mastroroberto M, Mazzolini M, Pisani L, Pandolfi P, Nava S, Morselli-Labate AM. A randomized placebo-controlled, double-blind trial on the management of post-infective cough by inhaled ipratropium and salbutamol administered in combination. Pulm. Pharmacol. Ther. 2014;29(2):224–232. doi:10.1016/j.pupt.2014.07.008.
    1. Coulson FR, Fryer AD. Muscarinic acetylcholine receptors and airway diseases. Pharmacol Ther. 2003;98(1):59–69.
    1. Ponsioen BP, Hop WC, Vermue NA, Dekhuijzen PN, Bohnen AM. Efficacy of fluticasone on cough: a randomised controlled trial. Eur Respir J. 2005;25(1):147–152.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj